|
TVIS44037964
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
161927395 |
161927395 |
q24.2 |
SLC4A10 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037965
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
15849045 |
15849045 |
p24.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037966
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
157554072 |
157554072 |
q24.1 |
ACVR1C |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037967
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
151889386 |
151889386 |
q23.3 |
ENSG00000283228, CACNB4 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037968
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
150291731 |
150291731 |
q23.3 |
LINC01818 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037969
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
145815906 |
145815906 |
q22.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037970
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
144054128 |
144054128 |
q22.3 |
GTDC1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037971
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
143091108 |
143091108 |
q22.2 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037972
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
142432289 |
142432289 |
q22.2 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037973
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr2 |
140481063 |
140481063 |
q22.1 |
LRP1B |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |